Ilc Therapeutics

Developer of immunotherapeutics for the treatment cancer

placeLanark, Scotland, United Kingdom calendar_todayFounded 2012 groups2 employees language ilctherapeutics.com

Registered entities

Innovation

11 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 154 times.

YearFilings
20207
20215
20226
20235
20245
20253
20261

Investor mix

4 investors on record; lead investors include Scottish Enterprise, Eos Advisory, Medical Incubator Japan.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon